selective inhibition of oncogenic transcription and other approaches in the treatment of sclc
Published 3 years ago • 152 plays • Length 37:43Download video MP4
Download video MP3
Similar videos
-
51:59
facilitating progress in the treatment of sclc
-
1:31:45
making the most of treatment advances in sclc
-
1:04:50
a new era has begun in the treatment of sclc: navigating novel therapeutic options and strategies
-
1:24:26
assessing the impact of therapeutic advances in sclc
-
28:23
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
1:09:47
how to select the right immunotherapy for first-line treatment of advanced nsclc
-
45:47
accelerating precision oncology research with nanopore sequencing
-
1:31:04
immunotherapy for sclc and the "four ps" in managed care—patient, provider, pharmacy, and plan
-
1:08:52
integrating new options into the sclc treatment arsenal to improve patient outcomes
-
36:55
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
1:00:27
improving outcomes in sclc through optimal integration of the latest therapies: expert perspectives
-
3:53
real-world molecular characterization of sclc subtypes
-
1:18:11
management of egfr-mutant lung cancer with central nervous system metastases
-
4:23
treatment approach in limited- and extensive-stage sclc
-
1:03:14
changing the game for es-sclc with immunotherapy and multidisciplinary collaboration
-
1:00:20
it’s precisely the time for more precision in genomic testing and targeted treatment of nsclc
-
1:39:03
everything you need to know about biomarker testing and treatment of genomically altered nsclc
-
4:37
frontline therapy approaches for small cell lung cancer